Meg Brousseau

Director at Novartis Institutes for BioMedical Research (NIBR) - Cambridge, Massachusetts, US

Victoria Ibenaminova

Associate director, Expert Trial Forecast Manager

Contact Victoria Ibenaminova

Chris Sarko

Executive Director - Global Discovery Chemistry

Contact Chris Sarko

Branda Wilhoite

Executive Director, Clinical Business Planning

Contact Branda Wilhoite

Mike Fiorino

Assoc. Director, Mechanical & Automated Devices, Technology & User Services

Contact Mike Fiorino

Edward Khokhlovich

Associate Director Data Science

Contact Edward Khokhlovich

View All Meg Brousseau's Colleagues
Meg Brousseau's Contact Details
HQ
617-871-8000
Location
Cambridge,Massachusetts,United States
Company
Novartis Institutes for BioMedical Research (NIBR)
Meg Brousseau's Company Details
Novartis Institutes for BioMedical Research (NIBR) logo, Novartis Institutes for BioMedical Research (NIBR) contact details

Novartis Institutes for BioMedical Research (NIBR)

Cambridge, Massachusetts, US • 3974 Employees
Major Drugs

Our people With more than 6,000 scientists, physicians and business professionals around the world, we have an open, entrepreneurial and innovative culture that encourages collaboration as we work to push the boundaries of science to change the practice of medicine. NIBR focuses on the following disease areas: • Autoimmunity, Transplantation, and Inflammatory Disease • Cardiovascular & Metabolic Diseases • Immuno-oncology • Infectious Diseases • Musculoskeletal Diseases • Neuroscience • Oncology • Ophthalmology • Respiratory Diseases NIBR has built expertise around several key technology competencies. Each competency combines automation and robotics, computational science, biology and irreplaceable drug discovery knowledge. By building expertise around key technologies, it can be more effectively applied across diseases that share similar mechanisms. • Analytical Sciences • Biologics • Biomarker Development • Chemistry • Developmental and Molecular Pathways • Drug Metabolism & Pharmacokinetics • Genomics Institute of the Novartis Research Foundation › Developing advanced technologies, ranging from cellular genomics and proteomics to combinatorial chemistry and structural biology • Imaging • Metabolism and Pharmacokinetics • Preclinical Safety • Proteomic Chemistry • Translational Medicine NIBR has locations in: • Basel, Switzerland • Cambridge, MA • East Hanover, NJ • Emeryville, CA (SF Bay Area) • San Diego, CA • Shanghai, China Thank you for taking an interest in the NIBR LinkedIn page. Please read Novartis' LinkedIn community guidelines: https://bit.ly/3yAl483

Gnf Cardiac Repari Novartis La Jolla Genomics Institute Of The Novartis Research Foundation Novartis Genomics Shifeng Novartis
Details about Novartis Institutes for BioMedical Research (NIBR)
Frequently Asked Questions about Meg Brousseau
Meg Brousseau currently works for Novartis Institutes for BioMedical Research (NIBR).
Meg Brousseau's role at Novartis Institutes for BioMedical Research (NIBR) is Director.
Meg Brousseau's email address is ***@novartis.com. To view Meg Brousseau's full email address, please signup to ConnectPlex.
Meg Brousseau works in the Major Drugs industry.
Meg Brousseau's colleagues at Novartis Institutes for BioMedical Research (NIBR) are Victoria Ibenaminova, Chris Sarko, Cynthia Hong, Alokesh Duttaroy, Branda Wilhoite, Mike Fiorino, Edward Khokhlovich and others.
Meg Brousseau's phone number is 617-871-8000
See more information about Meg Brousseau